HIV News Alert!

FDA approves TEMIXYS: New HIV Fixed Dose Drug Combination

November 27, 2018: FDA recently approved TEMIXYS (lamivudine and tenofovir disoproxil fumarate) tablets, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg. TEMIXYS was approved based on two bioavailability trials demonstrating similarity in exposures between TEMIXYS and the reference products, EPIVIR and VIREAD.

Click here to view label (PDF)